Rocket Lab Corporation reported results of its 2026 Annual Meeting of Stockholders held on May 20, 2026. Stockholders elected Class II director Edward H. Frank for a term expiring at the 2029 annual meeting, with 297,673,425 votes for, 55,896,708 withheld, and 116,546,800 broker non-votes.
Stockholders ratified Deloitte & Touche LLP as independent registered public accounting firm for the year ending December 31, 2026, with 467,440,986 votes for, 1,737,306 against, and 938,641 abstentions. They also approved, on a non-binding advisory basis, named executive officer compensation and a subsidiary merger eliminating a pass-through voting provision at Rocket Lab USA, Inc.
Rocket Lab Corporation entered an equity distribution agreement that allows sales of common stock and related forward transactions with an aggregate offering price of up to $3,000,000,000.
The company can sell shares through multiple banks as agents or principals and also use initially priced and collared forward sale agreements. Rocket Lab will receive cash only when these forward transactions are physically settled or when collared components are prepaid or settled, and it will pay commissions of up to 2.00% on sales under the program.
Rocket Lab Corporation registered an at-the-market equity program to offer up to $3,000,000,000 of common stock under a prospectus supplement dated May 20, 2026. The company may sell shares through appointed sales agents or enter into forward and collared forward transactions with specified financial counterparties.
The supplement states Rocket Lab will not initially receive proceeds from sales of borrowed hedging shares, expects to receive cash upon physical settlement or certain prepayments, and may use net proceeds to fund growth, potential acquisitions and general corporate purposes. The offering is subject to FINRA Rule 5121 conflict-of-interest procedures.
Rocket Lab Corp director-related entity reports share sales and a gift. An entity associated with director Alexander R. Slusky, identified as Abalone Cove LLLP, completed four open-market sales totaling 100,000 shares of Rocket Lab common stock on 2026-05-12 at weighted-average prices between $115.0500 and $120.0097 per share. Following these transactions, Abalone Cove LLLP held 434,675 shares indirectly. Separately, Slusky made a bona fide gift of 10,000 shares of common stock to a charitable donor advised fund and directly held 58,849 shares afterward.
Rocket Lab Corporation filed a prospectus supplement covering the resale of up to 2,277,002 shares of its common stock. These shares were issued on April 14, 2026 in a private placement tied to Rocket Lab’s previously announced acquisition of Mynaric AG under a Stock Purchase Agreement dated September 25, 2025.
The filing notes that the prospectus supplement was made pursuant to the Stock Purchase Agreement and is part of Rocket Lab’s existing automatic shelf registration statement on Form S-3ASR. A legal opinion and related consent from Goodwin Procter LLP regarding the shares are included as exhibits.
Rocket Lab Corporation filed a prospectus supplement registering 2,277,002 shares of its common stock for resale by selling stockholders. These shares were issued on April 14, 2026 as partial consideration for the acquisition of Mynaric AG. The company will not receive any proceeds from sales of the registered shares; proceeds will go to the selling stockholders. Shares outstanding were 578,750,990 as of April 30, 2026. The prospectus supplement states the shares may be sold on Nasdaq, in OTC trades, privately negotiated transactions or other permitted methods under the Plan of Distribution.
Rocket Lab Corporation reported strong growth for the three months ended March 31, 2026, with total revenue of $200.3 million, up from $122.6 million a year earlier, as both launch services and space systems expanded. Launch Services generated $63.7 million and Space Systems $136.7 million.
The company’s net loss narrowed to $45.0 million from $60.6 million, while gross profit more than doubled to $76.5 million. Cash, cash equivalents and marketable securities totaled $1.48 billion, supported by $450.3 million of common stock sold under an at-the-market equity program.
Rocket Lab converted $118.1 million of 4.25% convertible notes into 23.0 million shares, leaving $37.6 million outstanding, and ended the quarter with backlog of $2.22 billion, about 36% expected within 12 months. Management highlighted continued development of its Neutron medium-lift launch vehicle and recent acquisitions expanding space systems capabilities.
Rocket Lab Corporation reported record first-quarter 2026 revenue of $200.3 million, driven by strong growth in both product and service sales. Revenue rose 63.5% year over year to $127.5 million in product revenue and $72.9 million in service revenue, producing a GAAP gross margin of 38.2% and non-GAAP gross margin of 43.0%.
The company ended the quarter with a record $2.2 billion backlog and access to more than $2 billion in total liquidity, supported by $450.3 million raised through at-the-market equity offerings. Despite this growth, Rocket Lab posted a GAAP net loss of $45.0 million, or $0.07 per share, and an Adjusted EBITDA loss of $11.8 million, both improved versus the prior year.
Management highlighted record new launch contracts, completion of the Mynaric acquisition, a definitive agreement to acquire Motiv Space Systems, and progress on the Neutron launch vehicle. For the second quarter of 2026, the company guides revenue between $225 million and $240 million with continued GAAP and non-GAAP gross margin expansion and an expected Adjusted EBITDA loss between $20 million and $26 million.
Rocket Lab Corporation completed the acquisition of all issued and outstanding shares of Mynaric AG, a provider of laser optical communications terminals for air, space, and mobile applications. Rocket Lab paid aggregate consideration of $155.3 million, consisting of a nominal cash payment and 2,277,002 shares of its common stock, with 109,943 shares placed into an indemnity escrow.
The closing consideration was primarily based on a $75 million base purchase price plus additional investments made by the sellers, with a corresponding reduction in potential earnout consideration; the sellers are no longer eligible for further earnout payments. The Rocket Lab common stock issued in the deal was an unregistered issuance relying on Section 4(a)(2) of the Securities Act and/or Regulation D. Mynaric will continue to be headquartered in Munich, giving Rocket Lab its first European footprint and expanding its role in satellite laser communications alongside its existing launch and space systems business.